Literature DB >> 18764795

Locking solutions for hemodialysis catheters; heparin and citrate--a position paper by ASDIN.

John E Moran1, Stephen R Ash.   

Abstract

There is wide variation in the use of solutions to "lock" or fill tunneled central venous catheters for dialysis. Some centers use undiluted heparin concentrations ranging from 1000 to 10,000 U/ml and other centers place from 1000 to 10,000 U per lumen. Based on available evidence, it appears that heparin 1000 U/ml, or 4% sodium citrate are suitable choices for lock solution to maintain patency of tunneled central venous catheters for dialysis. Risks from systemic anticoagulation are lower with heparin 1000 U/ml and 4% sodium citrate, compared with higher concentrations of heparin (5000 and 10,000 U/ml). The need for use of tissue plasminogen activator for maintaining catheter patency is increased by using heparin lock at 1000 U/ml, vs. higher concentrations. Higher concentrations of heparin lock should be reserved for patients who have evidence of catheter occlusion or thrombosis when heparin is used at 1000 U/ml. Similar choices for lock solution are sensible for acute hemodialysis catheters. When heparin is used for catheter lock, the injected volume should not exceed the internal volume of the catheter.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18764795     DOI: 10.1111/j.1525-139X.2008.00466.x

Source DB:  PubMed          Journal:  Semin Dial        ISSN: 0894-0959            Impact factor:   3.455


  20 in total

1.  Heparin Drug Shortage Conservation Strategies.

Authors:  Cassandra D Benge; Abigail T Burka
Journal:  Fed Pract       Date:  2019-10

Review 2.  Prevention of catheter-related bloodstream infection in patients on hemodialysis.

Authors:  Michiel G H Betjes
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

3.  Does the heparin lock concentration affect hemodialysis catheter patency?

Authors:  D Maya Ivan; Tamorie Smith; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

4.  Convective Leakage Makes Heparin Locking of Central Venous Catheters Ineffective Within Seconds: Experimental Measurements in a Model Superior Vena Cava.

Authors:  Michael C Barbour; Patrick M McGah; Chin H Ng; Alicia M Clark; Kenneth W Gow; Alberto Aliseda
Journal:  ASAIO J       Date:  2015 Nov-Dec       Impact factor: 2.872

5.  Minimizing hemodialysis catheter dysfunction: an ounce of prevention.

Authors:  Timmy Lee; Charmaine Lok; Miguel Vazquez; Louise Moist; Ivan Maya; Michele Mokrzycki
Journal:  Int J Nephrol       Date:  2012-02-19

6.  Benefits and harms of citrate locking solutions for hemodialysis catheters: a systematic review and meta-analysis.

Authors:  Alexa Grudzinski; Arnav Agarwal; Neera Bhatnagar; Gihad Nesrallah
Journal:  Can J Kidney Health Dis       Date:  2015-04-02

7.  Anticoagulant properties of enoxaparin 400 IU/mL-40 % ethanol catheter lock solution.

Authors:  Laure Calvet; Michèle Piot; Claire Lartigue; Bertrand Souweine; Brigitte Tardy-Poncet
Journal:  Springerplus       Date:  2015-12-01

Review 8.  Antimicrobial lock solutions for preventing catheter-related infections in haemodialysis.

Authors:  Maria C Arechabala; Maria I Catoni; Juan Carlos Claro; Noelia P Rojas; Miriam E Rubio; Mario A Calvo; Luz M Letelier
Journal:  Cochrane Database Syst Rev       Date:  2018-04-03

9.  Use of the Tego needlefree connector is associated with reduced incidence of catheter-related bloodstream infections in hemodialysis patients.

Authors:  Steven M Brunelli; Levi Njord; Abigail E Hunt; Scott P Sibbel
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-04-03

10.  Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: A randomized controlled trial.

Authors:  Ali Akbar Beigi; Mirhadi Seyed HadiZadeh; Fereshteh Salimi; Hafez Ghaheri
Journal:  Adv Biomed Res       Date:  2014-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.